The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4875293 5925028 F 4875293-7 20051019 20051229 20060104 EXP TCI2005A04414 TAKEDA PHARMACEUTICALS COMPANY LTD. 77 YR F N 20051229 OT JAPAN

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4875293 1006799942 PS LANSAP 800 (LANSOPRAZOLE, CLARITHROMYCIN, AMOXICILLIN) 2 ORAL 1 CARD (0.5 CARD, 2 IN 1 D) PER ORAL D D 20406
4875293 1006825026 C NORVASC 1
4875293 1006825027 C GLYBURIDE 1
4875293 1006825028 C MICARDIS 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
4875293 1006799942 HELICOBACTER INFECTION

Outcome of event

Event ID OUTC COD
4875293 HO

Reactions reported

Event ID PT
4875293 DUODENAL ULCER
4875293 GASTRIC ULCER
4875293 MELAENA

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4875293 FGN
4875293 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4875293 1006799942 20050928